Medical injection system and method
By designing a liquid distribution device that uses two energy pulses, liquid injection without medical personnel is achieved, the problem of high viscosity liquid injection is solved, the injection pain is reduced and the safety and use-friendliness of the equipment is improved.
Patent Information
- Application Number
- CN202080041945.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-06-22
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2040-06-22
AI Technical Summary
The prior art equipment is difficult to realize automated and controlled injection of liquid into organisms, especially in the absence of medical personnel intervention, and is difficult to deal with molecular treatment of high viscosity liquids, and the safety and use-friendliness of injection equipment are insufficient. .
A liquid distribution device is designed to inject at least two energy pulses, using two energy sources to pierce the skin and inject liquid respectively, and the needle can be retracted to prevent accidental damage, and multiple needles are injected simultaneously through multiple needles. A smaller dose of liquid to reduce local tissue damage.
It realizes liquid injection without medical personnel intervention, reduces injection pain, extends equipment life, improves safety and use-friendly, and is suitable for a variety of liquid injections, including COVID-19 vaccines, especially high viscosity Molecular treatment of liquids.
Smart Images

Figure CN114080250B_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of U.S. Provisional Application No. 62 / 864,572, filed on June 21, 2019, entitled “Medical Injection Systems and Methods,” the entire contents of which are incorporated herein by reference.
[0003] Copyright and Legal Notices
[0004] A portion of the disclosure of this patent document contains copyrighted material. The copyright owner has no objection to anyone reproducing the patent document or the patent disclosure as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights. In addition, references to third-party patents or articles made herein should not be construed as an admission that the present invention is not entitled to precede such material by prior invention. Background Art
[0005] The present invention relates to devices that allow liquids, optionally including drugs, to be introduced into a living being in a controlled and automated manner. Summary of the invention
[0006] The present invention provides a liquid dispensing device adapted to dispense a quantity of liquid, preferably into a muscle of a living being, typically intramuscularly. The liquid dispensing device is also adapted to dispense a quantity of liquid into a living being intradermally or subcutaneously. The device has an energy storage device that provides energy in the form of at least two pulses. The first pulse is provided by a first energy source and is necessary to pierce the skin of the living being and insert a needle into an injection site. The second pulse is provided by a second energy source and is necessary to draw liquid out of a reservoir and into the living being, and to retract the needle from the living being. Together with a prescribed operating sequence of the device, the use of the two energy sources included in the device is optimized to provide at least two energy pulses.
[0007] The liquid dispensing device has a main housing enclosing the operating parts of the device, a liquid reservoir located in the main housing, an injection subassembly including a needle, and a trigger mechanism. The reservoir referred to in this specification is usually a barrel, but other reservoirs can also be used. The needle has a first end and a second end, suitable for docking with a septum arranged in the reservoir containing the liquid to be dispensed at the first end, and for insertion into the body of a living being at its second end. The mechanism contains the energy required to insert the needle into the body of a living being, dispense the liquid and retract the needle, and ensures that an operating cycle is completed without any other action by the user except triggering (which is usually done with a firm grip on the device). The first and second ends of the needle penetrate the corresponding surface respectively, while translating together in a direction parallel to the skin for the first end of the needle and in a direction substantially non-orthogonal to the surface of the skin of the living being for the second end of the needle. Once the septum is pierced, the needle is in communication with the reservoir and the device discharges the liquid into the body through the needle.
[0008] The present invention discloses three main embodiments. The second and third embodiments are alternative embodiments of the first embodiment. The specific contents of the second embodiment are as follows: Fig. 8A , 8B , 10A, 10B and 12. In addition, if for some operating steps, there is no specific figure in the second embodiment that specifically discloses this feature or step, the corresponding figure of the first embodiment represents all embodiments to support this feature or step in other embodiments. The difference between the first and second embodiments lies mainly in their mechanical proportions. The first embodiment is used for intramuscular application, that is, an injection of 2-3 cm into the patient's soft tissue is usually performed, while the second embodiment is used for subcutaneous application, that is, an injection of 1-2 mm into the patient's soft tissue is usually performed. Therefore, the first embodiment usually includes a long needle, the length of the long needle is suitable for penetrating 2-3 cm into the patient's tissue, and the second embodiment usually includes a short needle, the length of the short needle is suitable for penetrating 1-2 mm into the patient's soft tissue. Each of the first and second embodiments includes a barrel. The barrel of the first embodiment (containing about 1 ml of liquid) is suitable for containing concentrated drugs, while the barrel of the second embodiment (containing about 3 ml of liquid) is suitable for containing drugs of standard concentration.
[0009] In a third embodiment, the liquid dispensing device (via the user, elastic band or adhesive or pad) is placed against the skin of the organism and can be manually, automatically or remotely actuated to inject the liquid into the organism. This feature of the third embodiment can be easily combined with the first and second embodiments.
[0010] In the fourth embodiment, the two devices are superimposed (see Figure 2). This feature of the fourth embodiment can also be easily incorporated into the first three embodiments.
[0011] In a fifth embodiment, instead of a replaceable cartridge, the reservoir may be filled with liquid into a dedicated reservoir in the device itself, a feature which may also be easily incorporated into the other embodiments described herein.
[0012] The aim of the present invention is to provide an easy-to-use, user-friendly device that would enable anyone, even the patient themselves, to administer an injection of fluids without intervention from medical staff, particularly beneficial for the administration of a COVID-19 vaccine, thereby reducing the burden on the world's healthcare systems.
[0013] Another object of the present invention is to provide a user-friendly device that enables patients to self-inject without requiring the user to perform aggressive actions such as stabbing themselves.
[0014] Another object of the present invention is to provide a device that can meet the challenges of new molecular therapeutic innovations such as high viscosity liquids, whose properties would otherwise limit dosing options.
[0015] In one advantage, embodiments of the present invention use more than one needle, allowing several smaller doses of liquid to be injected into a living being simultaneously rather than one larger dose of liquid, resulting in less local tissue damage, thereby reducing injection pain for the patient.
[0016] Another object of the present invention is to provide an apparatus having an extended product life cycle.
[0017] Another object of the present invention is to provide a device that can retract the needle to prevent accidental injuries that may be caused by the exposed needle.
[0018] It is another object of the present invention to provide the option of injecting at an angle as the needle passes through the mandrel.
[0019] Another object of the present invention is to prevent unsanitary or potentially inadvertent reuse of the device, thereby providing a safer method of injecting fluids. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 is a perspective view of a first embodiment of a device according to the invention.
[0021] Figure 2A is a perspective view of a second embodiment of the device according to the invention.
[0022] Figure 2B FIG. 2 is a diagram showing two devices connected together according to a second embodiment of the present invention.
[0023] Figure 3 is a perspective view of a first embodiment of the present invention partially exploded in preparation for use.
[0024] Figure 4 is a perspective view of a second embodiment of the present invention partially exploded in preparation for use.
[0025] Figure 5A is a partial cross-sectional view of a mechanism according to the present invention.
[0026] Figure 5B is a cross-sectional view of the mechanism of the present invention.
[0027] Fig. 6A is a partial perspective view of a needle subassembly according to the present invention.
[0028] Figure 6B is a partial perspective view of an insertion subassembly and a needle subassembly according to the present invention.
[0029] Figure 6C Observed from the first rear perspective Figure 6B A partial perspective view of a subassembly.
[0030] Fig.6D Observed from below Figure 6B A partial perspective view of a subassembly.
[0031] Fig. 7A is a perspective view of an injection subassembly according to the present invention.
[0032] Figure 7B yes Fig. 7A A cross-sectional view of an injection subassembly showing an internal reservoir subassembly according to the present invention.
[0033] Fig. 8A According to the present invention Fig. 6A and Figure 6B A cross-sectional view of an alternative embodiment of an injection subassembly is shown.
[0034] Figure 8B yes Fig. 8A Another cross-sectional view of an alternative embodiment of .
[0035] Fig. 9A is a cross-sectional view of the mechanism of the present invention during step 6 of its use.
[0036] Figures 9B to 9D is a cross-sectional view of the mechanism of the present invention during its use step 7.
[0037] Figures 10A-10B is a cross-sectional view of the mechanism of an alternative embodiment of the present invention during its use in step 7.
[0038] Fig.11 is a cross-sectional view of the mechanism of the present invention during step 8 of its use.
[0039] Fig.12is a cross-sectional view of the mechanism of an alternative embodiment of the present invention during its use in step 8.
[0040] Fig.13 is a cross-sectional view of the mechanism of the present invention when it is used in step 9.
[0041] Figures 14A-14B is a cross-sectional view of the mechanism of the present invention in its use step 10 .
[0042] Fig.15 is a side view of the needle.
[0043] Fig.16 is a cross-sectional view of an alternative embodiment.
[0044] Those skilled in the art will appreciate that the elements in these figures are illustrated for simplicity and clarity, and are not necessarily drawn to scale. For example, the size may be exaggerated relative to other elements to help improve the understanding of the present invention and its embodiments. In addition, when the wording "first", "second", etc. is used herein, its use is expected to be used to distinguish similar elements and is not necessarily used to describe a sequential or chronological order. Moreover, relative wordings such as "front", "back", "top", and "bottom", etc. in the specification and / or claims are not necessarily used to describe exclusive relative positions. Therefore, those skilled in the art will appreciate that such wordings can be interchanged with other wordings, and the embodiments described herein can be operated in orientations different from those orientations explicitly described or otherwise described. DETAILED DESCRIPTION
[0045] The following descriptions are not intended to limit the scope of the present invention in any way, as they are exemplary in nature and are used to describe the best mode of the present invention known to the inventors as of the date of their filing. Therefore, changes may be made to the arrangement and / or function of any elements described in the disclosed exemplary embodiments without departing from the spirit and scope of the present invention.
[0046] Reference now Figure 1 , 2A and 2B, the device 1 of the present invention has a narrow form factor, convenient for carrying in a purse or pocket. Optionally, a pair of devices connected together can be provided for convenience.
[0047] Now please refer to Figure 3 and Figure 4The device 1 has a body 2 and a cover 4 which the user can remove to gain access to the button 14. An indicator 16 allows the user to check whether the device has been used or is ready for use. Once the cover 4 is removed, the user applies the device body 2 to the skin of a living being. An optional pressure-sensitive safety release mechanism 12 will only release the button 14 if the pressure applied to the skin of the living being is above a predetermined threshold, ensuring that the device is properly handled / maintained for optimal operation before allowing the button 14 to be pressed for triggering.
[0048] Now please see Figure 5A and 5B The mechanism 100 of the medical device 1 of the present invention is composed of five major subassemblies, which are contained in the main structure 102: a trigger mechanism 200, an insertion subassembly 300, a needle subassembly 400, a dispensing subassembly 500 and a reservoir subassembly 600 (such as Figure 7B ). The primary structure may be made of an injection molded polymer or any other suitable material.
[0049] Reference now Fig. 6A , the needle subassembly 400 is composed of a structure 402, which can be made of an injection molded polymer or any other suitable material. The needle subassembly structure 402 houses a needle 452 having an injection end 454 through which liquid is injected into the organism and a withdrawal end 456 to which liquid is withdrawn from a reservoir. The structure 402 has a suitable shape to be guided and oriented in the mechanism 100 and to provide latching and locking features for the operation of the mechanism 100. The needle 452 is made of stainless steel or any other suitable material.
[0050] Reference now Figures 6B to 6D . Prior to commencing an operating cycle of the mechanism 100, the insertion subassembly 300 is connected to the needle subassembly 400. The insertion subassembly 300 is comprised of a structure 302, which may be made of an injection molded polymer or any other suitable material. The structure 302 includes an insertion spring 352, which is compressed prior to operation of the device (e.g., during assembly). The spring may be made of stainless steel or any other suitable material. The structure 302 has an appropriate shape to be guided within the mechanism 100 and to provide latch and locking features 332, 334 for operation of the device. The structure also includes a release feature 336 for releasing the needle subassembly 400 from the insertion subassembly 300 during operating step 10 of the mechanism 100.
[0051] Reference now Fig. 7A and 7B. The dispensing assembly 500 includes a reservoir subassembly 600. The dispensing assembly 500 is composed of a structure 502 and a middle portion 512, which can be made of an injection molded polymer, or any other suitable material. The structure 502 and the middle portion 512 have appropriate shapes for guiding the mechanism 100 relative to adjacent components and providing latching, locking and triggering features 504, 506, 514 for the operation of the mechanism 100. The reservoir subassembly 600 is composed of a container 602, a septum 604, and contains a liquid 606 that is intended to be injected into the biological body through the operation of the device 1. The reservoir container 602 can be made of glass or any other suitable material. The septum 604 is made of a rubber-like, elastic, self-sealing material or any other suitable material, and includes the necessary features so that it can be pierced by the needle withdrawal end 456 and sealingly slide into the container 602, acting as a piston as required in step 7 of the operation of the mechanism 100. Features incorporated into the diaphragm 604 to ensure the desired behavior may include rigid or semi-rigid structures or a composite of these structures.
[0052] Now please refer to Figures 8A to 8B In an alternative embodiment, the device includes a standard barrel 601 that is readily available on the market, rather than a custom reservoir 600. The barrel 601 consists of a container 603, a stopper 605 that acts as a piston to fill the barrel at a fill line and an end line (not shown), and a septum 607. The barrel 601 contains a liquid 606 to be injected into the organism. In step 7, when the septum 607 is pierced by the needle withdrawal end 456, the stopper 605 will be used as a piston to expel the liquid 606 to be injected.
[0053] The operating sequence of the device is as follows.
[0054] 1. With device 1 connected to a second device 1 as a pair (see FIG. 2 ), the user separates the devices 1 so that one device can be used at a time.
[0055] 2. The user removes the cover 4 ( Figure 3 and Figure 4 ).
[0056] 3. The user sticks the device body 2 to the skin of the living body.
[0057] 4. Increase the pressure applied to the subject's skin until stable contact with the skin is achieved to allow injection, or until sufficient to cause the optional detector 12 to release the button 14 ( Figure 3 and 4 - at some predetermined pressure level). Alternatively, the optional detector 12 actuates the trigger mechanism 200, in which case we jump to step 6.
[0058] 5. The user presses the button 14 , actuating the trigger mechanism 200 .
[0059] 6. The trigger mechanism 200 releases the insertion subassembly 300 ( Fig. 9A ).
[0060] 7. The insertion subassembly 300 pushes the needle subassembly 400 until the needle injection end 454 can be inserted into the body to the injection depth and the needle withdrawal end 456 has pierced the reservoir septum 604 ( Figures 9B to 9D ).
[0061] 8. Once in this position, the insertion subassembly 300 is locked to the main structure 102 by the latching system 334, 134. Thus, the needle subassembly 400, still attached to the insertion subassembly 300, is also locked in place. At the same time, the dispensing assembly 500 is released, pushing the reservoir subassembly 600 onto the needle subassembly 400 ( Fig.11 and 12 ).
[0062] 9. The diaphragm 604 is displaced toward the bottom of the reservoir 602, which acts as a piston and dispenses the liquid 606 into the organism through the needle withdrawal end 456, through the needle 452, and through the needle injection end 454 ( Fig.13 ).
[0063] 10. Optionally, after the dispensing subassembly 500 empties the reservoir, the needle subassembly 400 is released from the insertion subassembly 300 and pushed back to its starting position, retracting the needle 452 until the needle injection end 454 is fully retracted into the main structure 102 ( Fig.14A and 14B ).
[0064] The key advantage brought about by the combination of the device and the sequence of operations described here is the preferred use of 2 energy sources (2 springs) contained in the device, using their maximum energy (when the springs are compressed to the maximum) to provide 2 energy pulses: the first pulse is necessary to pierce the skin of the organism and insert the needle into the injection site, and the second pulse is to withdraw the liquid from the reservoir and into the organism. The retraction of the needle is provided by the remaining energy of the second energy source.
[0065] The following Figures 9A to 9D 11 to 14B show further details of a first embodiment of the mechanism of the device 1 according to the invention. Figures 10A to 10B 12 show details of a second embodiment of the present invention.
[0066] Reference now Fig. 9A, referring to operation step 6 of mechanism 100, releasing the insertion subassembly 300 by the trigger mechanism 200 is represented as removing a locking element 232 from a latch feature consisting of an appropriate shape (latch 132 in the main structure 102) and another corresponding shape in the insertion subassembly structure 302 (latch 332 in the insertion subassembly).
[0067] Now refer to FIG. 9B to FIG. 9D Referring to step 7 of the operation of mechanism 100, insertion subassembly 300 begins to move under the urging of insertion spring 352. Since needle subassembly 400 is connected to insertion subassembly 300, needle subassembly 400 performs the same movement, causing withdrawal end 456 of needle 452 to pierce septum 604 (see Fig.9D ) and the injection end 454 of the needle 452 pierces the skin of the organism and penetrates to the injection depth below the skin of the organism.
[0068] Now please refer to Fig. 10A and 10B In the second embodiment, the needle withdrawal end 456 pierces the septum 607 of the barrel (as opposed to the septum 604 of the reservoir in the above embodiment). In the embodiment described in this paragraph, the injection depth is not "subcutaneous" (as in the embodiment of the previous paragraph), but "intradermal or subcutaneous" of the organism, for example, at a subcutaneous depth, which may be 1-2 mm below the skin surface.
[0069] Reference now Fig.11 , in operation step 8 of mechanism 100, upon reaching, needle subassembly structure 402 slides over middle portion 512 of dispensing assembly 500, opening a latch comprised of feature 514 of middle portion 512, latch feature 154 of main structure 102, and feature 504 of dispensing assembly structure 502. At this stage, a fluid connection from liquid container 602 through needle withdrawal end 456, through needle 452, through needle injection end 454 is opened, and spring 552 of the dispensing subassembly is released. At the same time, locking feature 334 (e.g., Figure 6C ) is snapped into a corresponding feature 134 of the main structure 102, securing the insertion subassembly 300 and the connected needle subassembly 400 so that they cannot move backward.
[0070] Reference now Fig.12 In the second embodiment, the dispensing assembly structure 502 moves relative to the container 603 of the barrel, pushing the stopper 605 in the container 603, and pushing the liquid 606 out of the container 603 through the needle withdrawal end 456, through the needle 452, through the needle injection end 454, and into the biological body.
[0071] Please note that the dimension x (such as Fig.12 as shown) or x′ (as shown Fig.16As shown) can be selected during the design phase of all embodiments shown herein, ranging from 1 mm or as small as 40 mm or larger, depending on the application requirements.
[0072] Reference now Fig.13 In operation step 9 of mechanism 100, when released, dispensing spring 552 pushes reservoir container 602 toward needle subassembly structure 402, which creates relative movement of diaphragm 604 toward the bottom of container 602, pushing liquid 606 out of container 602 through needle withdrawal end 456, through needle 452, through needle injection end 454, and into the biological body.
[0073] Reference now Fig.14A and 14B In the optional step 10 of the operation of the mechanism 100, when the reservoir container 602 is pushed toward the dispensing spring 552 of the needle subassembly structure 402 to the position where the trigger feature 506 of the dispensing subassembly structure 502 pushes the release feature 336, the needle subassembly 400 is released from the insertion subassembly 300 and begins to move back to its position before the start of the operation. While moving backward, the needle subassembly 400, under the push of the dispensing subassembly 500, retracts the needle 452 until the needle injection end 454 is fully retracted in the main structure 102.
[0074] Note that needle 452, optionally through mandrel 702, deforms the needle to prevent it from being reused. In one embodiment, the needle is deformed so as to be arched, thereby ensuring that the needle is bent because it is no longer straight, preventing it from passing through the mandrel again.
[0075] Reference now Fig.15 , Fig.15Some additional details of the needle 452 are shown. The first end of the needle, also referred to as the needle withdrawal end 456, is shown in more detail. In addition, the second end of the needle, also referred to as the needle injection end 454, is shown in more detail. The needle 452 includes an approximately 180° rotation in the region of the first end of the needle. The diameter D1 of the needle can be of a certain size in this region, while the diameter D2 of another portion of the needle can be larger, smaller, or the same as D1. The portion with diameter D1 remains in the housing 2 during operation, while the portion of the needle with diameter D2 is configured to bend and at least partially inserted into the patient's body during operation. The portion of the needle with diameter D2 is on one side of the injection end 454 of the needle. The needle 452 includes an internal channel (not shown) from one end of the needle to the other end. The diameter of the channel can be adapted to the viscosity of the liquid. However, the energy of one or both energy sources can also be adapted to the viscosity of the liquid. In a more preferred embodiment, the diameter size of the channel and the energy of one or both energy sources are adapted to the viscosity of the liquid. To ensure deformation and bending of the needle through the mandrel during operation, the diameter of the channel and the diameter D2 are selected to ensure appropriate deformation (bending and / or flexion). In a further embodiment, the diameter D2 of the needle can be varied to ensure appropriate bending and flexion. In another further embodiment, the channel can include a restrictor, such as a flow restrictor.
[0076] By Figure 5A-5B , 6A-6D, 7A-7B, 8A-8B, 9A-9D, 10A-10B, 11-13, 14A-14B and 16 are placed and fixed or combined into a housing (e.g., adjacent to or parallel to each other), the embodiments described in this specification can be configured to accommodate more than one needle 454 in parallel (and, optionally, side by side) so that the first ends 456 of these needles pierce the same septum or different septa of the same or different reservoirs. In another alternative, the embodiments described in this specification can be configured to handle more than one needle 454 in parallel so that the first ends 456 of these needles pierce at least two septa, each septum being assigned to a separate reservoir. Using more than one needle at the same time has multiple benefits.
[0077] - It allows the use of smaller needles which produce less pain when inserted into the organism.
[0078] - it allows the simultaneous injection of several smaller doses of fluid into the organism instead of one larger dose, thus producing less local tissue damage and therefore less injection pain for the patient; and
[0079] - It allows the injection of fluids at multiple locations, thus providing more effective treatment to the patient, as the injected fluid will diffuse more easily and quickly within the organism.
[0080] Reference is now made to an alternative embodiment which shows Fig.16 , wherein the injection end 454 of the needle is straight and remains straight during operation. In operation, the user places the device body against the skin of the organism so that the injection end of the needle 454 enters the organism substantially orthogonally. In this embodiment, the needle does not bend during operation. In addition, retraction of the needle can be accomplished by the user pulling the device away from the skin, just like in a standard syringe.
[0081] Note that all moving elements of the mechanism 100 that are subject to relative sliding or frictional forces may have a coating applied to their appropriate surfaces to ensure low friction.
[0082] The fluid for injection is usually one selected from the group consisting of peptides, proteins, hormones including insulin, calcitonin, calcitonin gene regulatory proteins, atrial natriuretic protein, colony stimulating factor, betaferon, erythropoietin (EPO), such as α., β. or γ.Interferons such as interferon, growth hormone, somatotropin, somatostatin, insulin-like growth factor (somatomedin), luteinizing hormone releasing hormone (LHRH), tissue plasminogen activator (TPA), growth hormone releasing hormone (GHRH), oxytocin, estradiol, growth hormone, leuprolide acetate, factor VIII, interleukins such as interleukin-2, and their analogs or antagonists, such as interleukin-1 radium (IL-1ra); analgesics such as fentanyl, sufentanil, butorphanol, buprenorphine, levorphanol, morphine, hydromorphone, hydrocodone, oxymorphone, methadone, lidocaine, bupivacaine, diclofenac, naproxen, noropyramine, and their analogs; anti-migraine analgesics such as sumatriptan, ergot alkaloids, and their analogs; anticoagulants such as heparin, hirudin, and their analogs; antiemetics such as scopolamine, ondansetron, domperidone, metoclopramide, and their analogs; cardiovascular agents, antihypertensive agents and vasodilators such as diltiazem, clonidine, nifedipine, verapamil, isosorbide mononitrate, organic nitrates, agents used in the treatment of heart disease, and their analogs; sedatives such as benzodiazepines, phenothiazines, and their analogs; chelating agents such as deferoxamine, and their analogs; antidiuretics such as desmopressin, vasopressin, and their analogs; antianginal agents such as fluorouracil, bleomycin, and their analogs; antineoplastic agents such as fluorouracil, oxazolidinone, bleomycin, and its analogs; prostaglandins, and their analogs; and chemotherapeutic agents, such as vincristine, and its analogs, treatments for attention deficit disorder, methylphenidate, fluvoxamine, bisoprolol, tacrolimus, sacrolimus, and cyclosporine, vitamins suspended in a liquid carrier, antitoxics, liquid medicines, prescriptions, antibodies, tocilizumab (Actemra), belentuzumab-vedotin (Adcretris), ofatumumab (Arzerra), bevacizumab (Avastin), belimumab (Benlysta), certolizumab (Cimzia), cetuximab (Erbitux), trastuzumab (Her ceptin), adalimumab (Humira), canakinumab (llaris), ranibizumab (Lucentis), gemtuzumab ozogamicin (Mylotarg), pertuzumab (Perjeta), Prolia (denosumab), Remicade (infliximab), Simponi (golimumab), Soliris (eculizumab), Stelara (ustekinumab), Tysabri (natalizumab), Vectibix (panitumumab), Xgeva (denosumab), Xolair (omalizumab), Yervoy (ipilimumab), and Zevalin (ibritumumab tiuxetan).
[0083] An advantage of the present invention is that it provides an easy-to-use, user-friendly device that allows anyone, even the patient themselves, to perform liquid injections without the intervention of medical staff, which is particularly advantageous for the injection of COVID-19 vaccines, thereby reducing the burden on the world's medical systems.
[0084] Another object of the present invention is to provide a user-friendly device that enables patients to self-inject without having to perform aggressive actions such as stabbing themselves.
[0085] In one advantage, the present invention provides a device that can meet the challenges of new molecular therapeutic innovations, such as high viscosity liquids, whose properties would otherwise limit dosing options.
[0086] In one advantage, the present invention provides a device that can simultaneously inject several smaller doses of a fluid into a living being rather than one larger dose, causing less local tissue damage, thereby reducing injection pain for the patient.
[0087] In one advantage, the present invention provides a device having an extended product life cycle.
[0088] In one advantage, the present invention provides a device that retracts the needle to prevent the exposed needle from causing possible inadvertent injury.
[0089] In one advantage, the present invention provides the option of injecting at an angle as the needle passes through the mandrel.
[0090] In one advantage, the present invention helps prevent unsanitary and perhaps inadvertent reuse of the device, thereby providing a safer means of injecting fluids.
[0091] The present invention can be summarized as follows.
[0092] 1. A fluid dispensing device 1 suitable for intramuscular and / or subcutaneous injection into a living body, the device having an energy storage device 352, 552 enclosed in a housing 2, the energy storage device providing energy in at least two pulses, the first pulse being required to pierce the skin of the living body and insert at least one needle 454 into the injection site, the second pulse being required to press the liquid out of at least one reservoir 602 and into the living body, and optionally to retract the at least one needle from the living body.
[0093] 2. A device according to feature set 1, wherein the first pulse is provided by a first energy source 352 and the second pulse is provided by a second energy source 552.
[0094] 3. An apparatus according to any one of the above feature sets, wherein the energy storage device 352, 552 is a spring.
[0095] 4. A device according to any one of the above-mentioned feature sets, wherein at least one needle 452 has a first end and a second end, and the two ends are suitable for piercing corresponding surfaces and translating together in one direction, so that when in use, the movement direction of the first end of the at least one needle is parallel to the patient's skin, and the movement direction of the second end of the at least one needle is basically not orthogonal to the patient's skin.
[0096] 5. A device according to any one of the above feature sets, wherein at least one needle passes through a core shaft that shifts the translation direction of at least one needle from a direction relative to the patient's skin, typically a parallel direction, to a non-orthogonal angle relative to the patient's skin.
[0097] 6. The device according to the above feature set, wherein the central axis 702 is suitable for deforming the needle 452 when it passes through.
[0098] 7. The device according to the above feature set, wherein the central axis 702 is suitable for causing deformation of the needle beyond the elastic limit of the needle, thereby preventing reuse of the device.
[0099] 8. A device according to any one of the above feature sets, wherein at least one thin, impermeable membrane 704 is adhered to the housing 2 so as to cover and seal at least one opening 706 in the device, through which at least one needle extends when an injection is actuated.
[0100] 9. A method for operating a device 1, comprising the following steps:
[0101] a. In the case where device 1 is connected to a second device 1 as a pair, disassembling device 1 so that one device can be used at a time;
[0102] b. Remove the cover 4, unless a film 704 is used to seal the device, at least one needle 454 can pierce the film, in which case no cover is required;
[0103] c. The device body 2 is pressed against the skin of the organism;
[0104] d. Optionally increasing the pressure on the organism's skin until it is sufficient to cause the optional detector 12 to release the button 14 for manual triggering in the next step, or, alternatively, the detector 12 automatically actuates the trigger mechanism 200, in which case, skipping to step f;
[0105] e. Pressing the button 14 actuates the trigger mechanism 200 which in turn releases the at least one insertion subassembly 300 .
[0106] f. Using the insertion subassembly 300 to push at least one needle subassembly 400 until the needle injection end 454 is inserted into the organism at an injection depth and the needle withdrawal end 456 has pierced at least one septum 604 of at least one reservoir 602;
[0107] h. When this position is reached, the insertion subassembly 300 is locked to the main structure 102;
[0108] i. The at least one needle subassembly 400 still connected to the at least one insertion subassembly 300 is locked in place, while the dispensing assembly 500 is released and the reservoir subassembly 600 is pushed toward the needle subassembly 400;
[0109] j. moving at least one diaphragm 604 as a piston toward the bottom of at least one reservoir 602 to distribute the liquid 606 through the needle withdrawal end 456, through the at least one needle 452, through the at least one needle injection end 454 into the organism; and
[0110] k. Remove the device.
[0111] 10. A method according to feature set 9, wherein, just prior to removal in step k, when the dispensing subassembly 500 has emptied at least one reservoir, the method includes the additional step of releasing at least one needle subassembly 400 from at least one insertion subassembly 300 and then pushing it back to its starting position, thereby retracting at least one needle 452 until the needle injection end 454 is fully retracted into the main structure 102, thereby preventing possible injury from the exposed needle.
[0112] 11. An operating method according to feature set 1, wherein the locking in step h is accomplished using latch system 334.
[0113] 12. A device according to any one of the above feature sets, wherein the diameter of at least a portion 754 of the internal channel of the needle 452 guiding the liquid is different from the diameter of another portion 756 of the internal channel of the needle.
[0114] 13. A device according to any one of the above feature sets, wherein at least two needles in a housing are used simultaneously to introduce liquid into a living body.
[0115] Furthermore, the present invention should be considered to include all possible functional combinations of each feature described in the present specification, the attached claims and / or the drawings, which may be considered novel, inventive and industrially applicable.
[0116] It should be understood that the particular embodiments shown and described herein are representative of the present invention and its best mode and are not intended to limit the scope of the present invention in any way.
[0117] As will be appreciated by those skilled in the art, the present invention may be embodied as a system, an apparatus, or a method.
[0118] Moreover, the system may contemplate the use, sale, and / or distribution of any goods, services, or information having similar functionality as described herein.
[0119] This specification and drawings should be considered in an illustrative manner, rather than a restrictive manner, and all modifications described herein are expected to be included within the scope of the invention claimed. Therefore, the scope of the present invention should be determined by the appended claims (as they currently exist or are modified or added later, and their legal equivalents), rather than being determined by the examples described above alone. For example, the steps recorded in any method or process claim can be performed in any order unless otherwise explicitly stated, and are not limited to the specific order given in any claim. In addition, the elements and / or parts recorded in any device claim can be assembled or otherwise configured in various arrangements in operation to produce results substantially the same as the present invention. Therefore, the present invention is not limited to the specific configurations recorded in the claims.
[0120] The benefits, other advantages, and solutions mentioned herein are not to be construed as critical, required, or essential features or components of any or all the claims.
[0121] When used herein, the words "comprises," "comprising," or any variation thereof, mean a non-exclusive listing of elements, such that any process, method, article, composition, or apparatus of the present invention that includes a list of elements does not include only those elements recited, but may also include other elements described in this specification. The use of the words "consisting of," or "consisting of," or "consisting essentially of," is not intended to limit the scope of the present invention to the listed elements named thereafter, unless otherwise indicated. Other combinations and / or modifications of the above-mentioned elements, materials, or structures used in the practice of the present invention may be changed or otherwise adapted to other designs by a skilled person without departing from the general principles of the present invention.
[0122] Unless otherwise noted, the above-mentioned patents and articles are hereby incorporated by reference to the extent they are not inconsistent with the present disclosure.
[0123] Further characteristics and modes of execution of the invention are described in the dependent claims.
[0124] Furthermore, the invention should be considered to include all possible combinations of each and every feature described in the specification, the attached claims and / or the drawings which may be considered novel, inventive and industrially applicable.
[0125] Additional features and functions of the present invention are described in the appended claims. Such claims are hereby incorporated by reference in their entirety into this specification and are considered a part of this filed application.
[0126] In the embodiments of the present invention described herein, multiple variations and modifications are possible. Although certain illustrative embodiments of the present invention are shown and described herein, many various modifications, variations and alternatives can be envisioned in the foregoing disclosure. Although the above description contains many specific details, these details should not be regarded as limitations on the scope of the present invention, but are instead regarded as illustrations of one or another preferred embodiment thereof. In some cases, some features of the present invention may be used without the corresponding use of other features. Accordingly, it is appropriate that the foregoing description is interpreted broadly and is understood to be given only by way of illustration and example, and the spirit and scope of the present invention are limited only by the claims that are finally issued in this application.
[0127] Reference numerals
[0128] The following components are Figure 1-3 public:
[0129] 1 Allocate equipment
[0130] 2 Body / housing of the dispensing device
[0131] 4. Lid
[0132] 12 Patient skin presence detector (optional) / pressure sensitive safety release mechanism
[0133] 14 Trigger Button
[0134] 16 Ready to use / used indicator device
[0135] The following components are Figures 4 to 14B public:
[0136] 100 Main institution
[0137] 102 Main structure
[0138] 132 Latch element
[0139] 134 Protrusion
[0140] 154 Latch element
[0141] 200 Trigger Mechanism
[0142] 232 Latch element
[0143] 300 Insert subcomponent
[0144] 302 Insert subcomponent structure
[0145] 332 Latch element
[0146] 334 Latch element
[0147] 336 Latch Release Lever
[0148] 352 Insert Spring / Energy Source
[0149] 400 Needle Subassembly
[0150] 402 needle subassembly structure
[0151] 452 needles
[0152] 454 Needle Injection Port
[0153] 456 pin extraction port
[0154] 500 Assign subcomponents
[0155] 502 Allocate subcomponent structure
[0156] 504 Latch element
[0157] 506 protrusion
[0158] 512 middle part
[0159] 514 Latch element
[0160] 552 Dispensing and retraction spring / energy source
[0161] 600 Reservoir Subassembly
[0162] 601 cartridge (standard cartridge or ready-made cartridge)
[0163] 602 Reservoir body
[0164] 604 Diaphragm
[0165] 606 Fluid
[0166] 702 Spindle
[0167] 704 anti-seepage membrane
[0168] 706 Opening
[0169] 754 Section of the inner passage
[0170] 756 Section of the inner passage
Claims
1. A liquid injection device (1) suitable for intramuscular injection and / or subcutaneous injection into a living body, The device (1) has an energy storage mechanism contained in a housing (2), the energy storage mechanism containing the energy required to complete an operating cycle without requiring the user to take any action other than triggering, the energy storage mechanism comprising a first preload spring (352) and a second preload spring (552), which provide energy in at least two pulses; The device comprises: A trigger mechanism (200) that generates a trigger; an insertion subassembly (300) movable when pushed by a first preload spring (352) under the operation of a trigger mechanism (200); a needle subassembly (400) movable by being pushed by the first preload spring (352) through the insertion subassembly (300) and comprising at least one needle (452); an injection subassembly (500) movable when being pushed by a second preload spring (552); and a reservoir subassembly (600) movable by being pushed by the second preload spring (552) through the injection subassembly (500) and comprising a reservoir (602) containing a fluid of predetermined viscosity and a diaphragm (604) sliding in the reservoir (602) in a sealed manner, The first preload spring (352) is positioned to urge the needle subassembly (400) through the insertion subassembly (300) in a first direction toward the injection subassembly (500); The second preload spring (552) is positioned to urge the injection subassembly (500) in a second direction, which is opposite to the direction in which the first preload spring (352) urges the insertion subassembly (300); The first pulse provides a first amount of energy from the first preload spring, which is sufficient to extend the at least one needle (452) a sufficient distance to move the needle subassembly (400) in the first direction through the insertion subassembly (300) so that the withdrawal end of the needle (452) penetrates the septum (604), and the injection end of the needle (452) penetrates the patient's skin and is inserted into the skin a further distance to reach the injection site, and the second pulse provides a second amount of energy from the second preload spring, which is suitable for pressing the fluid out of the at least one reservoir (602) into the biological body and retracting the at least one needle from the biological body, and moving the injection subassembly (500) in the second direction to generate relative movement of the septum (604) relative to the reservoir (602) by the needle subassembly (400) to push out the fluid, and moving the reservoir subassembly (600) and the needle subassembly (400) together in the second direction when the injection subassembly (500) moves to a certain position to retract the injection end of the needle (452) from the biological body.
2. The device according to claim 1, wherein the withdrawal end and the injection end are adapted to pierce corresponding surfaces and translate together in one direction so that when in use, the movement direction of the withdrawal end of the needle is parallel to the patient's skin, while the movement direction of the injection end of the needle is substantially non-orthogonal to the patient's skin.
3. A device according to any one of the preceding claims, wherein the needle passes through a mandrel which shifts the translation direction of the needle from one direction, typically parallel, relative to the patient's skin to a non-orthogonal angle relative to the patient's skin.
4. Apparatus according to the preceding claim 3, wherein said mandrel (702) is adapted to deform the needle (452) as it passes through it.
5. The device according to the above claim 4, wherein the mandrel (702) is suitable for deforming the needle beyond the elastic limit of the needle, thereby preventing the repeated use of the device.
6. A device according to any one of claims 1, 2, 4, 5 above, wherein at least one thin, impermeable membrane (704) is adhered to the housing (2) so as to cover and seal at least one opening (706) in the device through which the needle extends when the injection is actuated.
7. A device according to claim 3 above, wherein at least one thin, impermeable membrane (704) is adhered to the housing (2) so as to cover and seal at least one opening (706) in the device through which the needle extends when the injection is actuated.
8. The device according to any one of the above claims 1, 2, 4, 5, 7, wherein the diameter of at least a portion of the internal channel of the needle (452) guiding the liquid is different from the diameter of another portion of the internal channel of the needle.
9. The device according to claim 3 above, wherein the diameter of at least a portion of the inner channel of the needle (452) guiding the liquid is different from the diameter of another portion of the inner channel of the needle.
10. The device according to the above claim 6, wherein the diameter of at least a part of the inner channel of the needle (452) guiding the liquid is different from the diameter of another part of the inner channel of the needle.
11. The device according to any one of claims 1, 2, 4, 5, 7, 9, 10, wherein at least two needles in one housing are used simultaneously to introduce liquid into a living body.
12. The device according to claim 3 above, wherein at least two needles in one housing are used simultaneously to introduce liquid into the living body.
13. The device according to claim 6 above, wherein at least two needles in one housing are used simultaneously to introduce liquid into the living body.
14. The device according to claim 8 above, wherein at least two needles in one housing are used simultaneously to introduce liquid into the living body.
Citation Information
Patent Citations
Fluid dispenser
US20180133395A1
